20:49 , Jan 20, 2017 |  BC Week In Review  |  Financial News

EnteroMedics completes follow-on

On Jan. 18, metabolic medical device company EnteroMedics Inc. (NASDAQ:ETRM) raised $16.5 million through the sale of 751,412 class A units at $5.31 and 12,531 class B units at $1,000 in a follow-on underwritten by...
07:00 , Sep 26, 2016 |  BC Week In Review  |  Financial News

EnteroMedics proposes follow-on

EnteroMedics Inc. (NASDAQ:ETRM), St. Paul, Minn.   Business: Endocrine/Metabolic   Date announced: 2016-09-20   Type: Follow-on   To be raised: Up to $5.8 million   Units: TBD   Price prior: $0.14   Underwriter: Ladenburg Thalmann   Note: Each class A unit comprises two...
07:00 , Sep 7, 2016 |  BC Extra  |  Company News

Management tracks

Hearing loss company Decibel Therapeutics Inc. (Cambridge, Mass.) named Michael Su as CSO; Paula Cobb as SVP of strategy, portfolio and programs; and John Lee as SVP of pharmaceutical development. Su was SVP of R&D...
07:00 , Jul 26, 2016 |  BC Extra  |  Politics & Policy

FDA unveils draft guidance on real-world evidence for devices

In draft guidance released Tuesday, FDA outlined its thinking on the use of real-world evidence in making regulatory decisions about medical devices. The agency described factors it would consider when evaluating the relevance, reliability and...
23:44 , Apr 22, 2016 |  BC Extra  |  Company News

Management tracks

Oncology company FLX Bio Inc. (South San Francisco, Calif.) hired Rekha Hemrajani as COO. She was CFO and SVP of business and financial operations at 3-V Biosciences Inc. (Menlo Park, Calif.). Dermatology company Cipher Pharmaceuticals...
08:00 , Dec 21, 2015 |  BioCentury  |  Strategy

Preferential practices

Facing calls from its members and patient groups for a framework on how patient preference studies for drugs should be designed and executed, BIO enlisted Parent Project Muscular Dystrophy to help create a set of...
08:00 , Nov 9, 2015 |  BC Week In Review  |  Financial News

EnteroMedics proposes private placement of convertible notes and warrants

EnteroMedics Inc. (NASDAQ:ETRM), St. Paul, Minn.   Business: Endocrine/Metabolic, Gastrointestinal   Date announced: 2015-11-05   Type: Private placement of convertible notes and warrants   To be raised: Up to $25 million   Shares outstanding prior: 106.4 million   Placement agent: Northland...
07:00 , Sep 7, 2015 |  BioCentury  |  Strategy

Back to School: Changing the subject

No longer content with a walk-on role as research subjects, and empowered by access to more information and the necessity of shouldering a bigger share of the healthcare bill, patients are demanding a speaking role...
07:00 , Jun 29, 2015 |  BioCentury  |  Product Development

Would you rather?

Medical product developers, regulators and patients are starting to apply social science to life science, using techniques created to measure the preferences of individuals and groups to shape how medicines are designed, tested, regulated and...
00:31 , Apr 8, 2015 |  BC Extra  |  Company News

Management tracks

Obesity device company EnteroMedics Inc. (NASDAQ:ETRM) named Scott Shikora EVP of medical affairs and CMO, effective June 1. Shikora was the company's consulting CMO. He is an associate professor of surgery at Harvard Medical School...